Clinical trial
Pilot Study: The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Peri-implant Mucositis
NCT04838054 is registered in ClinicalTrials.gov with Rowpar Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study: The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Peri-implant Mucositis
- Lead sponsor
- Rowpar Pharmaceuticals, Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 15, 2018
- Completion date
- March 4, 2020
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
peri-implant mucositis